Immunotech Biopharm Market Cap

Immunotech Biopharm has a market cap or net worth of 524.88 million as of May 7, 2026. Its market cap has decreased by -71.35% in one year.

Market Cap

524.88M

Enterprise Value

839.15M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.85

Market Cap Chart

Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 524.88M, a decrease of -93.22%. That is a compound annual growth rate of -37.00%.

Market Cap History

Date	Market Cap	% Change
May 6, 2026	568.10M	-68.60%
Dec 31, 2025	1.81B	52.87%
Dec 31, 2024	1.18B	-54.00%
Dec 29, 2023	2.57B	7.99%
Dec 30, 2022	2.38B	-72.51%
Dec 31, 2021	8.67B	50.90%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Jul 10, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kintor Pharmaceutical	1.44B
CANbridge Pharmaceuticals	1.21B
Shanghai Bio-heart Biological Technology	1.09B
Transcenta Holding	971.77M
Sunho Biologics	970.43M
Brii Biosciences	959.94M
JW (Cayman) Therapeutics Co.	932.97M
3D Medicines	932.46M

Market Cap Rankings